Julia Anastas joined Silk Road Medical in May 2020 and brings with her over 25 years of regulatory affairs experience in medical devices, serving in both large organizations and small start-ups. Julia most recently served as Vice President of Regulatory Affairs at BTG plc, a specialist healthcare company focused on interventional medicine, where she was responsible for the Interventional Vascular and Interventional Pulmonology groups. Prior to BTG Julia led regulatory affairs groups supporting a variety of therapy areas including bariatrics, reproductive medicine, diabetes, urology, and virology. However, the majority of her career has been spent supporting interventional vascular devices, including positions held at Abbott Vascular and Guidant Corp., where she authored the PMA for the first FDA-approved carotid stent system. Julia holds a B.A. in Chemistry and Master of Public Health degrees, both from Boston University.